WikiLeaks – big pharma revelations next…?

In a rare, two-hour interview conducted in London on November 11, Julian Assange said that he’s still sitting on a trove of secret documents, about half of which relate to the private sector. And WikiLeaks’ next target will be a major American bank. “It will give a true and representative insight into how banks behave at the executive level in a way that will stimulate investigations and reforms, I presume,” he said, adding: “For this, there’s only one similar example. It’s like the Enron emails.”

“You could call it the ecosystem of corruption. But it’s also all the regular decision making that turns a blind eye to and supports unethical practices: the oversight that’s not done, the priorities of executives, how they think they’re fulfilling their own self-interest. The way they talk about it”.

Let’s just walk through other industries. What about pharmaceutical companies?

“Yes. To be clear, we have so much unprocessed stuff, I’m not even sure about all of it. These are just things I’ve briefly looked at or that one of our people have told me about”.

Let’s all hope that WikiLeaks will be throwing its spotlight on the pharmaceuticals indiustry sooner rather than later.

Read the entire interview here.

%d bloggers like this: